ERBB2 and neoplasm: Overall, these data indicate that a sharp increase in HER2 may result in triggering cell intrinsic defensive systems, whereas a low-level sustained presence of HER2 can shift cell identity, via chromatin remodelling, towards tumour-promoting phenotypes.